Minerva Neurosciences, Inc. Interest Expense
Minerva Neurosciences, Inc. (NERV) reported Interest Expense of $0 for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2014-11-06
- Minerva Neurosciences, Inc. interest expense for the quarter ending 2014-09-30 was $0.00.
- Minerva Neurosciences, Inc. interest expense for the quarter ending 2014-06-30 was $1.73M.
| Period end | Interest Expense 3 month | Interest Expense 6 month |
|---|---|---|
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 | $1.73M derived: sum of 2 quarters · filed 2014-11-06 |
| 2014-06-30 | $1.73M 10-Q · filed 2014-08-07 | $2.04M 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |